Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease

被引:73
|
作者
Nobili, Valerio
Manco, Melania
Ciampalini, Paolo
Diciommo, Vincenzo
Devito, Rita
Piemonte, Fiorella
Comparcola, Donatella
Guidi, Roberto
Marcellini, Matilde
机构
[1] Bambino Gesu Pediat Hosp, Res Inst, Liver Unit, I-00165 Rome, Italy
[2] Bambino Gesu Pediat Hosp, Res Inst, Dept Endocrinol, I-00165 Rome, Italy
[3] Bambino Gesu Pediat Hosp, Res Inst, Epidemiol Unit, I-00165 Rome, Italy
[4] Bambino Gesu Pediat Hosp, Res Inst, Dept Pathol, I-00165 Rome, Italy
[5] Bambino Gesu Pediat Hosp, Res Inst, Dept Mol Med, I-00165 Rome, Italy
关键词
D O I
10.1530/eje.1.02288
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Prevalence of non-alcoholic fatty liver disease (NAFLD) among children is increasing dramatically. It is unclear why some patients develop steatohepatitis (NASH), fibrosis and cirrhosis from steatosis, and others do not. A role for leptin has been claimed. This study aims to evaluate the relationship between leptin, insulin resistance (IR) and NAFLD in children. Design and methods: In 72 biopsy-proven NAFLD children (aged 9-18 years; 51M/21F), fasting leptin and its soluble receptor (sOB-R) were measured; free leptin index (FLI) was calculated as leptin/sOB-R: IR was estimated by homeostasis model assessment (HOMA-IR) and insulin sensitivity index (ISI-comp): glucose tolerance by oral glucose tolerance test (OGTT). Percentage of total body fat (TBF) by dual-energy X-ray absorptiometry (DXA) was available in 65 patients. Results: Prevalence of diabetes, impaired fasting and/or after load glucose tolerance was 11%. HOMA-IR and ISI-comp values were 2.55 +/- 1.39 and 4.4 +/- 2. NASH was diagnosed in 38 and simple steatosis in 25 children: diagnosis was indeterminate in 29 children. Increased fibrosis, mostly of mild severity, was observed in 4 1 patients. Median NAFLD activity (NAS) score was 3.42 +/- 1.60. According to histology, levels of leptin and FLI increased as steatosis (leptin from 11.9 +/- 6.3 in score I to 17.4 +/- 6.9 in score 2 (P=0.01) and 22.2 +/- 6.8ng/ml in score 3 (P < 0.001); FLI 2.56 +/- 1.40, 3.57 +/- 0.34, 4.45 +/- 0.64 respectively (P = 0.05)); ballooning (from 13.7 +/- 6.7 in score 1 to 1.7 +/- 7.5 in score 2 (P = 0.001) and 22.1 +/- 7.1 ng/ml in score 3 (P = 0.01); FLI 2.8 1 +/- 1.50, 3.40 +/- 1.65, 4.57 +/- 1.67 (P = 0.01 between 0 and 2)); fibrosis (from 14.3 +/- 7 to 18.3 +/- 6.9: P = 0.03; FLI 3.03 +/- 1.57 vs 3.92 +/- 0 7 7: P < 0.05) and NAS score (score 1-2: 12.9 +/- 6.9; score 3-4: 17 6.9 (P = 0.01); score 5-7: 2 2.9 +/- 7.5 ng/ml (P = 0.03): FLI 2.70 +/- 1.53, 3.12 +/- 1.53, 4.58 +/- 1.57 P=0.01 and P=0.05 between 1-2 vs 3-4 and 3-4 vs 5-7 respectively) worsened. Higher leptin correlated with more severe steatosis, ballooning and NAS score (r(o)=0.6, 0.4 and 0.6 respectively; for all P < 0.001); FLI with ballooning (r(o)=0.4, P < 0.0001), steatosis (r(o)=0.5, P < 0.0001) and NAS score (r(o)=0.5, P < 0.0001.). Conclusions: Leptin and liver injury correlated independently of age, BMI and gender in the present study. Nevertheless, any causative role of leptin in NAFLD progression could be established. Thus, studies are needed to define whether the hormone plays a major role in the disease.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 50 条
  • [1] Insulin resistance, serum leptin and fibrosis in non-alcoholic fatty liver disease (NAFL)
    Born, T
    Ong, JP
    Schlauch, K
    Elariny, H
    Younoszai, A
    Goodman, Z
    Christensen, A
    Assmann, J
    Chandhoke, V
    Younossi, ZM
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A748 - A748
  • [2] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
  • [3] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
  • [4] Leptin Profile and Insulin Resistance Modulate Hepatocyte Apoptosis and Fibrosis in Non-Alcoholic Fatty Liver Disease
    Canbakan, Billur
    Senturk, Hakan
    Tuncer, Murat
    Koroglu, Emine
    Atay, Kadri
    Kepil, Nuray
    Sonsuz, Abdullah
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S945 - S945
  • [5] Leptin and non-alcoholic fatty liver disease
    Balci, H.
    Canbakan, B.
    Bolayirli, I. M.
    Ozbay, G.
    Hacibekiroglu, M.
    Senturk, H.
    [J]. CLINICAL CHEMISTRY, 2006, 52 (06) : A10 - A10
  • [6] Role of Leptin in Non-Alcoholic Fatty Liver Disease
    Jimenez-Cortegana, Carlos
    Garcia-Galey, Alba
    Tami, Malika
    del Pino, Pilar
    Carmona, Isabel
    Lopez, Soledad
    Alba, Gonzalo
    Sanchez-Margalet, Victor
    [J]. BIOMEDICINES, 2021, 9 (07)
  • [7] Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease
    Xiao-Dong Huang
    [J]. World Journal of Gastroenterology, 2008, (18) : 2888 - 2893
  • [8] Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease
    Huang, Xiao-Dong
    Fan, Yan
    Zhang, Hen
    Wang, Ping
    Yuan, Jing Ping
    Li, Ming-Jie
    Zhan, Xi-Yan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (18) : 2888 - 2893
  • [9] The role of leptin in progression of non-alcoholic fatty liver disease
    Ikejima, K
    Okumura, K
    Lang, T
    Honda, H
    Abe, W
    Yamashina, S
    Enomoto, N
    Takei, Y
    Sato, N
    [J]. HEPATOLOGY RESEARCH, 2005, 33 (02) : 151 - 154
  • [10] Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease
    Angulo, P
    Alba, LM
    Petrovic, LM
    Adams, LA
    Lindor, KD
    Jensen, MD
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (06) : 943 - 949